What is Perella Weinberg’s current reputation on the street for deal flow, exits, culture etc? I have not seen many recent threads discussing PWP in 2019/2020. How would you compare it to banks like Evercore or Moelis?
Trending Content - Investment Banking Forum
| +189 | Americas M&A League Table Q2 Updated | 75 | 15h |
| +141 | New Article: Dramatic Slide as UBS #22 (US) & New Leadership Desperately Needed | 36 | 6h |
| +118 | Restructuring: Anti-climactic Experience | 31 | 8h |
| +86 | IB Net Worth / Savings Check | 38 | 3h |
| +75 | A COMPLETE GUIDE TO SUMMER INTERNSHIP RECRUITING | 12 | 2d |
| +51 | Boutique firm wants access to my LinkedIn? | 40 | 1d |
| +48 | Woman who emptied Knicks trashcan on street then stole it was DEI exec, worked at JPMorgan Chase | 12 | 11h |
| +40 | Investment Banking is Hard | 17 | 1d |
| +31 | PWP vs BofA | 24 | 4h |
| +30 | AI + Financial Modelling | 7 | 1h |
Career Resources
Evercore > Moelis >> PWP
Lol "Prospect"
Lol "EU_prospect"
Have heard good things about the culture. Deal flow/exits perspective is EVR>MC>PWP.
PWP has the best exit opps to business school (HBS)
True, founders really help with that. Was more referring to traditional IB exits, not biz school.
I'd agree that it goes EVR > Moelis > PWP, but Perella is still doing well. They've been expanding and are getting some pretty significant deals, including https://www.wsj.com/articles/treasury-department-selects-wall-street-ba…</a">airline restructuring from the treasury, impressive given they're pretty small.
Not that PWP getting the mandate isn't impressive, but the other boutiques are likely advising the debtors and could not be on the deal because of conflict.
The same can be said for the BBs and why they didn't get these mandates - very high possibility that they've done some form of lending or syndication.
How Does PWP compare to firms like Greenhill or Guggenheim? Recruiting at all three right now.
Guggenheim > PWP > Greenhill
Think PWP/Gugg could be a tossup depending on the group
Perella does a lot of work with O&G and significantly more deal flow for rx
Believe Guggenheim RX (Millstein) is stronger than PWP RX You're right about O&G Houston
How would you rank PWP versus a bulge bracket?
Would probably put it in the same area as CS/Barclays/Citi if you're in one of their larger hubs. I know people who regularly chose it over those BB's if they had both offers, but that was also for the London office. Another thing to note is that PWP is pursuing a pretty aggressive expansion strategy in certain markets (like Europe), as shown by them opening up two new offices in Paris and Germany. Ultimately, it definitely ranks lower than some other EB's, but it also is on an upward trajectory.
What about over B of A or JPM or MS?
What about over B of A or JPM or MS?
What about over B of A or JPM or MS?
I personally know a few that chose PWP over B of A and JPM, but it's much more of a toss up between the two than CS/Citi/Barclays, which is why I didn't include it in the previous group. Ultimately, a lot of it can also come down to whether or not you prefer an EB or a BB. Those that chose PWP over B of A or JPM had always preferred the EB structure, or they wanted to pursue something that BB's don't offer, such as RX.
BB : EB GS/MS : Evercore/PJT JPM: Lazard/Moelis/Centerview BAML/CS/Barclays/Citi : Guggenheim/PWP/Greenhill DB / UBS : Rothschild / Jefferies
Pretty accurate
Centerview is definitely on par with EVR/PJT (and I say that as an EVR employee). Huge deals, huge pay.
Speaking with friends across a variety of EBs, including PJT EVR and HL, I've actually gotten the impression that exits-wise Moelis might be better than you think. Sweat shop reputation plus diverse deal experience makes a Moelis-minted analyst something any PE shop can trust. EVR places analysts into industry groups right off the bat, so if you're doing RE or FIG, your exits may be narrowed to those types of funds.
Jefferies isn't even a boutique what are you even on about
this is not accurate at all.. PWP is a tier above
Cannot speak for the whole firm, but know two guys that worked in the healthcare M&A team and had decent exits:
C-suite of a notable MedTech start-up (think series B level, 100+ employees etc)
MM Healthcare PE firm in London
I've been told that the HC team is quite good there.
did the analyst exit into the c suite?
It was an Associate and yes, right to the C-suite
Solid reputation & dealflow. Not as much of a meatgrinder as a couple of its peers
Does anyone have info on what it’s strongest groups are and how they compare to other top groups on the street? Does PWP have any groups that place really well?
Also, someone mentioned the b-school pipeline. Is that actually true?
Think that PWP is on par with Moelis. EVR definitely > PWP in terms of PE exits. Would also consider size of firm versus size of deals. PWP is much, much smaller than Moelis or EVR in terms of # of analysts.
My impression is :
EVR / PJT / Centerview
Moelis / PWP / Lazard
Rothschild / Guggenheim
.
agree about all of that, but gugg/roths have a significant disadvantage save for a couple of coverage groups at gugg and rx at roths
I agree - the mass of prospects and college kids who repost ranks miss the reality which is that being at any of those shops (and more) will give you all the looks you need. The disparity in exits tend to be less on the firm name but more the quality of the analyst, which tend to be better at certain firms, as well as the deal flow and experience that the analyst gets which can then inform their interview and their overall finance knowledge.
Would you say people get looks from headhunters for MFs at firm like Greenhill as well?
Does anyone have perspective on which groups are considered their best?
In Ldn industrials longest standing franchise.. pretty slick deals look what they did where Elliott was involved.
They just launched a restructuring team in Ldn that has pretty good perspective as they hired top senior talent from GS RX and PJT. Also landed v good mandates in such a short time see Pizza Express. The only thing in this regard I have heard is that they want to do company / shareholder mandate exclusively as this makes sense given background of 2 Goldman bankers.
Healthcare & Rx
Anyone have any updates on PWP's recruiting? I heard they'll reach out shortly regarding interviews.
GS vs PJT? (both NYC) in terms of Exits/prestige/hours??
This is the completely wrong thread on which to be asking this question
BB:EB GS/MS : PJT, EVR, CVP JPM: LAZ, MOE, PWP BAML/Citi/CS/Barclays: Guggenheim/Greenhill UBS/DB: Rothschild, Jefferies, HL
Quia quibusdam et natus laudantium eos quaerat voluptas. Consectetur sapiente impedit quis impedit consequatur ut. Fugiat et sit doloribus rerum omnis autem. Velit ipsum numquam aut in quam aut cupiditate.
Nesciunt iusto sit velit cum suscipit repudiandae repellat. Unde fugit suscipit ad pariatur blanditiis quia necessitatibus.
Quibusdam nisi nostrum consequuntur ut dicta voluptas. Et rerum quia rem atque.
Et optio provident impedit numquam pariatur est asperiores voluptas. Modi unde aliquam sed id. Nihil aut unde quibusdam saepe vitae beatae. Qui optio unde harum ut mollitia.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Non ipsum libero ut aut culpa soluta. Tenetur eos aperiam sunt perspiciatis consequatur expedita provident rem. Ab quia sit reprehenderit quo odit perferendis dolor.
Quia odit alias quis beatae. Nesciunt ea aut tempora officiis illo. Dolores reiciendis nulla eos aut.
Omnis temporibus officia vel quidem eaque fugiat facere. Qui accusantium odio et ad et voluptatibus.
Voluptas inventore recusandae consequatur modi. Ut similique ex ratione quod corrupti rerum. Voluptas aliquam qui voluptatibus voluptas.
Qui culpa dolor quasi nostrum sint. Id ratione nobis voluptas repellendus cum iste. Eos et ad aut molestias pariatur. Tenetur error ea dolores pariatur possimus. Iusto maxime quaerat odit eius. Et sunt tempore qui. Et architecto sapiente dolorum numquam.
Non suscipit praesentium ut porro. Ex id voluptates unde aut ad quia ipsam. Culpa ea labore optio facere accusamus natus aliquam.
Vero quo voluptate natus rerum consequuntur sint iure. Aut debitis repellendus at quia deserunt. Ex explicabo possimus ipsa voluptatem blanditiis aut aliquam. Minus quae excepturi dignissimos ducimus aliquam nesciunt distinctio est. Atque excepturi veniam a quo error ipsum dolor.
Fuga reiciendis in at expedita maxime libero dolor. Accusamus at voluptatem hic aut neque cum. Nulla voluptatem sapiente ut a occaecati. Ut alias aliquam est est quis nisi. Hic amet reprehenderit cumque rerum.